In 2018, CDC made a $15 million commitment to the first close of Novastar Ventures Africa Fund II.
Novastar will catalyse growth in businesses that provide basic goods and services at scale and economic opportunities for low income, mass markets. If successful, the fund can help prove the venture impact investing model in Africa.
- Investment type
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund manager:
- Novastar Ventures
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
Investments made by this fund
|Investment name||Country||Region||Sector||Start date||Status|
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. The company aims to improve pharmaceutical cag
| Sure Chill|
Sure Chill is a platform cooling technology. It uses water to enable continuous cooling from inconsistent power.
| Metro Africa Xpress (MAX.NG)|
MAX is an online delivery platform working to fix Africa's last-mile delivery and online-retail problems.
|Nigeria||Africa||Other consumer services||June 2019||Active|